DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells.

DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Abstract Text:

Ryohei Sasaki,Yoko Suzuki,Yuko Yonezawa,Yosuke Ota,Yoshiaki Okamoto,Yusuke Demizu,Peng Huang,Hiromi Yoshida,Kazuro Sugimura,Yoshiyuki Mizushina,Ryohei Sasaki,Yoko Suzuki,Yuko Yonezawa,Yosuke Ota,Yoshiaki Okamoto,Yusuke Demizu,Peng Huang,Hiromi Yoshida,Kazuro Sugimura,Yoshiyuki Mizushina,

Among the vitamin K (VK) compounds, VK3 exhibits distinct cytotoxic activity in cancer cells and is thought to affect redox cycling; however, the underlying mechanisms remain unclear. Here we demonstrate that VK3 selectively inhibits DNA polymerase (pol) gamma, the key enzyme responsible for mitochondrial DNA replication and repair. VK3 at 30 microM inhibited pol gamma by more than 80%, caused impairment of mitochondrial DNA replication and repair, and induced a significant increase in reactive oxygen species (ROS), leading to apoptosis. At a lower concentration (3 microM), VK3 did not cause a significant increase in ROS, but was able to effectively inhibit cell proliferation, which could be reversed by supplementing glycolytic substrates. The cytotoxic action of VK3 was independent of p53 tumor suppressor gene status. Interestingly, VK3 only inhibited pol gamma but did not affect other pol including human pol alpha, pol beta, pol delta, and pol epsilon. VK1 and VK2 exhibited no inhibitory effect on any of the pol tested. These data together suggest that the inhibition of pol gamma by VK3 is relatively specific, and that this compound seems to exert its anticancer activity by two possible mechanisms in a concentration-dependent manner: (1) induction of ROS-mediated cell death at high concentrations; and (2) inhibition of cell proliferation at lower concentrations likely through the suppression of mitochondrial respiratory function. These findings may explain various cytotoxic actions induced by VK3, and may pave the way for the further use of VK3.

DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Publishing Authors By Initials

R Sasaki,Y Suzuki,Y Yonezawa,Y Ota,Y Okamoto,Y Demizu,P Huang,H Yoshida,K Sugimura,Y Mizushina,R Sasaki,Y Suzuki,Y Yonezawa,Y Ota,Y Okamoto,Y Demizu,P Huang,H Yoshida,K Sugimura,Y Mizushina,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer science

VOLUME: 99

Page Numbers: 1040-8

Journal Abbreviation: Cancer Sci.

ISSN: 1349-7006

DAY: 27

MONTH: 02

YEAR: 2008

DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101168776

DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells.

AFFILIATION: Division of Radiology, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho, Chuou-ku, Kobe City, Hyogo 650-0017, Japan.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Sci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells Related Publications

• 1-Deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae.
• Anti-tumor effect of orally administered spinach glycolipid fraction on implanted cancer cells, colon-26, in mice.
• DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells.
• Hymenoic acid, a novel specific inhibitor of human DNA polymerase lambda from a fungus of Hymenochaetaceae sp.
• Inhibitory effects of cholesterol derivatives on DNA polymerase and topoisomerase activities, and human cancer cell growth.
• Inhibitory effects of vitamin K3 on DNA polymerase and angiogenesis.
• Novel azaphilones, kasanosins A and B, which are specific inhibitors of eukaryotic DNA polymerases beta and lambda from Talaromyces sp.
• Pyranicin, a non-classical annonaceous acetogenin, is a potent inhibitor of DNA polymerase, topoisomerase and human cancer cell growth.